Search Results
287 results
Your search is now limited to «Sleep-Disordered Breathing» expert search.
PR Newswire 03/20/2019 18:53
The FDA's approval of Sunosi is based on data from the Treatment of Obstructive sleep apnea and Narcolepsy Excessive Sleepiness (TONES) Phase 3 clinical program, which included four randomized placebo-controlled studies that demonstrated the superiority of Sunosi relative to placebo.
More from PR Newswire:
MassDevice 03/20/2019 15:25
Nyxoah said it has won the CE Mark for its novel hypoglossal nerve stimulation therapy for treating obstructive sleep apnea (OSA). The Genio system is a battery-free, leadless and minimally invasive neurostimulator designed to deliver bilateral hypoglossal nerve stimulation for moderate to severe obstructive sleep apnea patients who have failed conventional continuous positive airway pressure (CPAP) […]. The post Nyxoah sleep apnea neuro-stim therapy gains CE Mark appeared first on MassDevice .
More from MassDevice:
DoctorsLounge 03/20/2019 13:00
Patients with type 2 diabetes are at increased risk for developing obstructive sleep apnea, independent of other factors, according to a study published online March 12 in Diabetes Care.
More from DoctorsLounge:
ClinicalTrials.gov 03/20/2019 09:35
Condition : Obstructive Sleep Apnea (OSA) Interventions : Drug: MK-7264; Drug: Placebo Sponsor : Merck Sharp & Dohme Corp. Not yet recruiting.
More from ClinicalTrials.gov:
GlobeNewswire 03/20/2019 09:00
This has significant health and economic implications, as half of all patients with cardiovascular disease are believed to suffer from sleep apnea and the total cost of unmanaged obstructive sleep apnea is $150 billion each year in the United States alone.
More from GlobeNewswire:
News-Medical.net 03/20/2019 02:26
The data indicate that improving sleep habits, as well as screening for and potentially treating sleep apnea may help improve maternal infant outcomes in this high-risk population.
More from News-Medical.net:
Medindia.com 03/20/2019 02:05
A growing number of studies suggest that obstructive sleep apnea (OSA), or "sleep-disordered breathing," is associated with a higher risk for memory problems and for problems with thinking and making decisions.
More from Medindia.com:
It is estimated that 22 million Americans suffer from sleep apnea, with 80 percent of the cases of moderate and severe obstructive sleep apnea undiagnosed.
More from Middle East North Africa Financial Network (MENAFN):
March 19th, 2019 Editors Cardiology, ENT, Medicine Obstructive sleep apnea (OSA) is often caused by the tongue blocking the airway during night-time breathing.
More from Medgadget - Internet Journal of Emerging Medical Technologies:
Medical Xpress 03/19/2019 13:11
In this sleep study, 56 patients with obstructive sleep apnea (OSA) were fitted with a custom mandibular advancement splint (OAT) and had their midsagittal mandibular movement tracked.
More from Medical Xpress:
WN.com 03/19/2019 06:02
Sleep Aid Devices Market is projected to be valued at US$ 29,200 Mn by the end of 2026.
More from WN.com:
Technology Org 03/19/2019 05:40
That means such products are not tested to meet federal standards, and doctors cannot rely on their readings to diagnose possible sleep disorders, such as obstructive sleep apnea.
More from Technology Org:
FeedNavigator 03/18/2019 08:12
Background Sympathetic nervous system activation plays a pivotal role in obese patients with obstructive sleep apnea (OSA), contributing to increased cardiovascular risk.
More from FeedNavigator:
Bio-Medicine.Org 03/17/2019 12:59
A desire to provide a simple, accurate, reliable solution to those struggling with sleep-disordered breathing and sleep apnea drove the decision to use Itamar’s WatchPAT technology.
More from Bio-Medicine.Org:
A 12-year-old girl with normal neurodevelopment and narcolepsy type 1 presented with unexpected central apneas in response to sodium oxybate (SO). The patient underwent overnight polysomnography on SO (2.75 + 2.5 grams) which showed an apnea-hypopnea index of 4.3 events/h, and all the events were central apneas. A majority of central apneas clustered at about 1.5 hours after the first dose of SO. Remarkably, after a second dose of SO that was 0.25 grams smaller, she did not exhibit clusters of central sleep apneas. However, she did experience similar but milder breathing abnormalities that did not meet criteria to be scored as central apneas or hypopneas. Based on this observation, there may be an association between SO treatment and the de.
More from Journal of Clinical Sleep Medicine:
Healio News 03/15/2019 15:48
Type 2 diabetes increases the risk for obstructive sleep apnea in adults, and obesity, diabetes-related foot disease and depression are among the risk factors for the condition, according to findings published in Diabetes Care.
More from Healio News:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications